Companies
STOXX 600Health Care· France
SAN
Status-Quo-PlayerSanofi
$81.02
+2.03%
Open $79.53·Prev $79.41
Delayed
STATUS-QUO-PLAYER
Power Core
Sanofi's moat is the compounding clinical evidence and prescriber lock-in created by Dupixent's multi-indication biologics platform, reinforced by irreplaceable global vaccine manufacturing infrastructure.
Published14 Apr 2026
UniverseSTOXX 600
SectorHealth Care
↑
Direction of Movement
upward